NASDAQ:URGN
UroGen Pharma Ltd [URGN] Chief Medical Officer makes an insider sale of 10,000 shares worth 250,000.
Daniel Torres
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. UroGen Pharma ...
URGN price target predicted to rise nearly 23.5 in 12 months
Daniel Torres
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. UroGen Pharma ...
URGN short interest declines, indicating growing optimism among investors
Daniel Torres
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. UroGen Pharma ...
URGN price target predicted to rise nearly 23.5 in 12 months
Roman Campbell
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
Chief Financial Officer Degnan Chris sale 2,203 shares of UroGen Pharma Ltd [URGN]
Roman Campbell
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
URGN Stock Sees Surge of Approximately 18.59% in Last Five Days
Samantha Gray
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. UroGen Pharma ...
